Tonix Pharmaceuticals Holding Corp. (TNXP)
3.01
-0.23
(-7.10%)
USD |
NASDAQ |
Nov 13, 16:00
3.06
+0.05
(+1.66%)
After-Hours: 19:59
Tonix Pharmaceuticals Profit Margin (Quarterly) : -309.4% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -309.4% |
| June 30, 2026 | -299.4% |
| March 31, 2026 | -584.4% |
| December 31, 2025 | -870.3% |
| September 30, 2025 | -972.9% |
| June 30, 2025 | -1.42K% |
| March 31, 2025 | -692.8% |
| Date | Value |
|---|---|
| December 31, 2024 | -856.2% |
| September 30, 2024 | -503.6% |
| June 30, 2024 | -3.57K% |
| March 31, 2024 | -601.9% |
| December 31, 2023 | -723.0% |
| September 30, 2023 | -701.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | -14.20% |
| Inovio Pharmaceuticals, Inc. | -16.46K% |
| Nektar Therapeutics | -401.0% |
| Karyopharm Therapeutics, Inc. | -200.5% |
| Minerva Neurosciences, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -80.42% |
| Return on Assets | -70.48% |
| Return on Invested Capital | -80.03% |
| Gross Profit Margin (Quarterly) | 89.00% |
| Operating Margin (Quarterly) | -321.6% |
| Return on Net Operating Assets | -277.6% |